विधियों की तुलना करें
चुनी हुई विधियों की आमने-सामने समीक्षा करें; भिन्नता वाली पंक्तियाँ रेखांकित हैं।
| SCORAD Index (SCORing Atopic Dermatitis)× | EASI (एक्जिमा क्षेत्र और गंभीरता सूचकांक)× | |
|---|---|---|
| क्षेत्र | त्वचा विज्ञान | त्वचा विज्ञान |
| परिवार | Process / pipeline | Process / pipeline |
| उद्भव वर्ष≠ | 1993 | 2001 |
| प्रवर्तक≠ | European Task Force on Atopic Dermatitis (ETFAD) | Hanifin JM, Thurston M |
| प्रकार | Clinician-rated | Clinician-rated |
| मौलिक स्रोत≠ | Kunz B, Oranje AP, Labrèze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10-19. DOI ↗ | Hanifin JM, Thurston M, Omoto M, et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Experimental Dermatology. 2001;10(1):11-18. DOI ↗ |
| उपनाम | SCORAD Index | EASI Index |
| संबंधित≠ | 3 | 2 |
| सारांश≠ | The SCORAD is a comprehensive clinician-administered tool for measuring the extent and severity of atopic dermatitis (eczema). Developed by the European Task Force on Atopic Dermatitis in 1993, it combines objective clinical assessment with subjective symptom reporting. It is the gold standard for atopic dermatitis severity in clinical trials and dermatology practice. | The EASI is a structured, clinician-administered tool for assessing the extent and intensity of atopic dermatitis across the body. Developed by Hanifin and colleagues in 2001, it divides the body into four regions with weighted area factors, ensuring proportional contribution to total score. EASI has become the primary objective severity measure in atopic dermatitis clinical trials and is recommended by international regulatory authorities (FDA, EMA). |
| ScholarGateडेटासेट ↗ |
|
|